Exploring Optimal Photographic Parameters for Standardized Facial Aesthetics Analysis
OPTIFACE
1 other identifier
observational
60
1 country
1
Brief Summary
The main objective of this research is to identify the focal length that allows the most accurate and reproducible 2D assessment of facial aesthetics, without introducing significant distortion. Ultimately, this will enable the establishment of a standardized photography protocol for maxillofacial and aesthetic surgery, facilitating harmonized pre- and post-operative assessments and improving communication between healthcare providers and patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 16, 2025
CompletedStudy Start
First participant enrolled
June 16, 2025
CompletedFirst Posted
Study publicly available on registry
July 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedJuly 4, 2025
July 1, 2025
3 months
June 16, 2025
July 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Identify the focal length setting for optimal assessment of facial aesthetics on 2D photographs
Attractiveness score from 1 to 5 (from very unattractive to very attractive, respectively). The images will be evaluated by 4 independent raters (2 experts: facial surgeons, and 2 non-experts) based on the focal length used: 50 mm, 85 mm, 105 mm, 135 mm, and 200 mm.
Up to 3 months
Interventions
Evaluation of the photographs by four independent raters
Eligibility Criteria
Participants in the study will be individuals aged 18 years or older, with no recent facial injuries or lesions, and who have provided written informed consent to participate.
You may qualify if:
- Age ≥ 18,
- Signed informed consent
You may not qualify if:
- Facial anomalies or Wounds
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hôpital NOVOlead
Study Sites (1)
Hôpital NOVO - Site Pontoise
Pontoise, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nicolas JABALLAH-MAGDELEINE
Hôpital NOVO
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 16, 2025
First Posted
July 4, 2025
Study Start
June 16, 2025
Primary Completion
September 1, 2025
Study Completion
September 1, 2025
Last Updated
July 4, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share